Showing 2,581 - 2,600 results of 21,342 for search '(( significant ((level decrease) OR (mean decrease)) ) OR ( significant decrease decrease ))', query time: 0.65s Refine Results
  1. 2581
  2. 2582
  3. 2583
  4. 2584
  5. 2585

    Negative Intrinsic Viscosity in Graphene Nanoparticle Suspensions Induced by Hydrodynamic Slip by Adyant Agrawal (22492518)

    Published 2025
    “…These simulations robustly confirm that the intrinsic viscosity decreases with increasing aspect ratio and becomes negative beyond a threshold ≈5.5, providing a molecular-level confirmation of this behavior in a realistic graphene–water system. …”
  6. 2586

    Negative Intrinsic Viscosity in Graphene Nanoparticle Suspensions Induced by Hydrodynamic Slip by Adyant Agrawal (22492518)

    Published 2025
    “…These simulations robustly confirm that the intrinsic viscosity decreases with increasing aspect ratio and becomes negative beyond a threshold ≈5.5, providing a molecular-level confirmation of this behavior in a realistic graphene–water system. …”
  7. 2587
  8. 2588
  9. 2589
  10. 2590
  11. 2591
  12. 2592

    Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
  13. 2593
  14. 2594
  15. 2595

    Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis by Lin Y.-T. (17065287)

    Published 2025
    “…After transitioning to HD, body weight decreased significantly, with a reduction of -2.8 kg at one month, -5.3 kg at three months, and -7.5 kg one year post-transition. …”
  16. 2596
  17. 2597
  18. 2598
  19. 2599
  20. 2600

    ELISA of the key proteins. by Du Leng (20421711)

    Published 2024
    “…ELISA showed a slight decrease in the serum levels of CDK1, ITGA5, ITGB5, and CD44 during and after treatment.…”